• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾源性系统性纤维化:一组病例提示钆可能是病因学因素。

Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.

作者信息

Moreno-Romero J A, Segura S, Mascaró J M, Cowper S E, Julià M, Poch E, Botey A, Herrero C

机构信息

Department of Dermatology, Hospital Clinic de Barcelona, Universitat de Barcelona, Villarroel 170, Barcelona 08036, Spain.

出版信息

Br J Dermatol. 2007 Oct;157(4):783-7. doi: 10.1111/j.1365-2133.2007.08067.x. Epub 2007 Jul 11.

DOI:10.1111/j.1365-2133.2007.08067.x
PMID:17627792
Abstract

Nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy is a rare fibrotic condition that presents in patients with a history of renal disease. The aetiology is unknown, but it has recently been proposed that gadolinium, a paramagnetic contrast agent, may be a trigger of this disease. We report three patients with NSF with a history of use of gadolinium in magnetic resonance angiography a few weeks before the onset of symptoms. In the future, gadolinium should probably be avoided as much as possible in renal insufficiency patients until its role in the development of NSF is clarified.

摘要

肾源性系统性纤维化(NSF)或肾源性纤维性皮肤病是一种罕见的纤维化病症,见于有肾脏疾病史的患者。病因不明,但最近有人提出,顺磁性造影剂钆可能是这种疾病的触发因素。我们报告了3例NSF患者,他们在症状出现前几周有在磁共振血管造影中使用钆的病史。未来,在肾功能不全患者中,可能应尽可能避免使用钆,直到其在NSF发病中的作用得到阐明。

相似文献

1
Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.肾源性系统性纤维化:一组病例提示钆可能是病因学因素。
Br J Dermatol. 2007 Oct;157(4):783-7. doi: 10.1111/j.1365-2133.2007.08067.x. Epub 2007 Jul 11.
2
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.钆双胺造影剂“激活”成纤维细胞:肾源性系统性纤维化的一个可能原因。
J Pathol. 2008 Apr;214(5):584-93. doi: 10.1002/path.2311.
3
Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.肾源性系统性纤维化/肾源性纤维性皮肤病:放射科医生入门指南
J Comput Assist Tomogr. 2008 Jan-Feb;32(1):1-3. doi: 10.1097/RCT.0b013e31805d08ee.
4
Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?肾源性系统性纤维化:钆是谜题中缺失的一环吗?
Cutis. 2008 May;81(5):421-6.
5
Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?组织钆沉积和纤维化类似于肾源性系统性纤维化(NSF)-亚临床肾源性系统性纤维化?
J Am Acad Dermatol. 2010 Feb;62(2):337-42. doi: 10.1016/j.jaad.2009.04.010. Epub 2009 Nov 24.
6
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.肾源性系统性纤维化:一种与钆相关的肾功能不全患者的纤维化疾病。
Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii66-9. doi: 10.1136/ard.2008.102475.
7
Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.含钆磁共振成像造影剂与肾源性系统性纤维化:一项病例对照研究。
Am J Kidney Dis. 2008 Jun;51(6):966-75. doi: 10.1053/j.ajkd.2007.12.036. Epub 2008 Mar 25.
8
Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.肾源性系统性纤维化:与钆的关系及对光分离置换法的反应
Arch Dermatol. 2007 Aug;143(8):1025-30. doi: 10.1001/archderm.143.8.1025.
9
[Nephrogenic systemic fibrosis and use of MR contrast media].[肾源性系统性纤维化与磁共振造影剂的使用]
Tidsskr Nor Laegeforen. 2009 Jan 29;129(3):180-2. doi: 10.4045/tidsskr.09.33117.
10
Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.肾源性系统性纤维化:肾衰竭患者中的一种神秘疾病——钆基造影剂在病因中的作用及静脉注射硫代硫酸钠的有益效果
Clin J Am Soc Nephrol. 2007 Mar;2(2):258-63. doi: 10.2215/CJN.03250906. Epub 2007 Feb 7.

引用本文的文献

1
A Perspective on Modelling Metallic Magnetic Nanoparticles in Biomedicine: From Monometals to Nanoalloys and Ligand-Protected Particles.生物医学中金属磁性纳米粒子建模的展望:从单金属到纳米合金及配体保护粒子
Materials (Basel). 2021 Jun 28;14(13):3611. doi: 10.3390/ma14133611.
2
Is it time to relax nephrogenic systemic fibrosis guidelines and safely offer magnetic resonance imaging to more patients?是时候放宽肾源性系统性纤维化指南,安全地为更多患者提供磁共振成像了吗?
Quant Imaging Med Surg. 2019 Nov;9(11):1918-1921. doi: 10.21037/qims.2019.10.11.
3
Pathophysiology of gadolinium-associated systemic fibrosis.
钆相关系统性纤维化的病理生理学
Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F1-F11. doi: 10.1152/ajprenal.00166.2016. Epub 2016 May 4.
4
An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.一项关于确定钆基造影剂与肾源性系统性纤维化之间关联的更新研究。
PLoS One. 2015 Jun 15;10(6):e0129720. doi: 10.1371/journal.pone.0129720. eCollection 2015.
5
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.用于模拟多发性硬化症血脑屏障完整性的扫描分层病例对照抽样。
Stat Med. 2015 Sep 10;34(20):2872-80. doi: 10.1002/sim.6520. Epub 2015 May 4.
6
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.通过学术-法律合作推进药物警戒:以钆基造影剂与肾源性系统性纤维化为例——药物不良事件与报告研究(RADAR)报告
Br J Radiol. 2014 Oct;87(1042):20140307. doi: 10.1259/bjr.20140307.
7
Predicting breakdown of the blood-brain barrier in multiple sclerosis without contrast agents.预测多发性硬化症中无造影剂的血脑屏障破裂。
AJNR Am J Neuroradiol. 2012 Sep;33(8):1586-90. doi: 10.3174/ajnr.A2997. Epub 2012 Mar 22.
8
Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases.肾源性系统性纤维化:408例经活检确诊病例的综述。
Indian J Dermatol. 2011 Jan;56(1):65-73. doi: 10.4103/0019-5154.77556.
9
Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis.患者肾源性系统性纤维化相关的皮肤成纤维细胞持续激活。
Ann Rheum Dis. 2010 Nov;69(11):2017-23. doi: 10.1136/ard.2009.127761. Epub 2010 Jun 22.
10
Nephrogenic systemic fibrosis in liver disease: a systematic review.肝病相关性肾源性系统性纤维化:系统评价。
J Magn Reson Imaging. 2009 Dec;30(6):1313-22. doi: 10.1002/jmri.21983.